Skip to main navigation Skip to search Skip to main content

Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.

  • Corinne Bosquet
  • , Justano Castaño
  • , Zsolt Csaba
  • , Micheal Culler
  • , Pascal Dournaud
  • , Jacques Epelbaum
  • , Wasyl Feniuk
  • , Anthony Harmar
  • , Rebecca Hills
  • , Leo Hofland
  • , Daniel Hoyer
  • , Patrick Humphrey
  • , Hans-Jürgen Kreienkamp
  • , Amelie Lupp
  • , Shlomo Melmed
  • , Wolfgang Meyerhof
  • , Anne-Marie O'Carroll
  • , Yogesh Patel
  • , Terry Reisine
  • , Jean-Claude Reubi
  • Marcus Schindler, Herbert Schmid, Agnes Schonbrunn, Stefan Schulz, John Taylor, Giovanni Tulipano, Annamaria Vezzani, Hans-Jürgen Wester

Research output: Contribution to journal › Article (Academic Journal) › peer-review

169 Downloads (Pure)

Abstract

Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors
Original languageEnglish
Number of pages17
JournalIUPHAR/BPS Guide to PHarmacology CITE
DOIs
Publication statusPublished - 16 Sept 2019

Fingerprint

Dive into the research topics of 'Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database.'. Together they form a unique fingerprint.

Cite this